StockData
Zura Bio Ltd logo

Zura Bio Ltd (ZURA) shareholders

ZURANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 5/30
$0.95−0.01 (-1.32%)

Close on Nov 19, 2026Market cap $91.74MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
75.7%
73M of 96M shares
Institutional holders
95
26 new, 24 sold out
Net institutional buying
6M
In Q2 2026
Insider trades, 12 months
1 buys · 0 sales
Net bought $12.50M

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
AI Biotechnology LLC
Joint filing with Access Industries Holdings LLC (18.20%), Access Industries Management, LLC (18.20%) and 1 more
19,699,07118.20%13D (active) amendmentFeb 26, 2026
Len Blavatnik
Joint filing with AI Biotechnology LLC (19.90%), Access Industries Holdings LLC (19.90%) and 1 more
14,326,09019.90%13D (active)May 21, 2025
UGS Capital LLC
Joint filing with Athanor Capital (15.70%)
11,581,40215.70%13D (active)Jan 23, 2026
Athanor Capital
Joint filing with UGS Capital LLC (15.70%)
11,581,40215.70%13G (passive)Dec 29, 2025
Bong Y. Koh
Joint filing with Venrock Healthcare Capital Partners III, L.P. (9.90%), VHCP Co-Investment Holdings III, LLC (9.90%) and 4 more
9,816,3849.90%13G (passive) amendmentMar 31, 2026
Aaron Cowen
Joint filing with Suvretta Capital Management, LLC (9.90%), Averill Master Fund, Ltd. (8.80%)
9,524,2639.90%13G (passive) amendmentMar 31, 2026
Bong Y Koh
Joint filing with Venrock Healthcare Capital Partners III, L.P. (9.90%), VHCP Co-Investment Holdings III, LLC (9.90%) and 4 more
7,031,2719.90%13G (passive) amendmentMar 31, 2025
VHCP Management EG, LLC
Joint filing with Venrock Healthcare Capital Partners III, L.P. (9.90%), VHCP Co-Investment Holdings III, LLC (9.90%) and 4 more
6,353,3539.90%13G (passive) amendmentJun 30, 2025
JPMorgan Chase & Co.4,672,4167.50%13G (passive)Jun 30, 2025
Access Industries Holdings LLC
Joint filing with AI Biotechnology LLC (9.90%), Access Industries Management, LLC (9.90%) and 1 more
4,388,5609.90%13G (passive) amendmentDec 31, 2023
Ms. Lillian Nordahl
Joint filing with Great Point Partners, LLC (5.12%), Dr. Jeffrey R. Jay, M.D. (5.12%)
3,170,1945.12%13G (passive)May 8, 2025

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of ZURAValueChange% of portfolio
Suvretta Capital Management, LLC9,443,0019.80%$55.71M+376,0001.02%
VR Adviser, LLC6,434,9906.68%$37.97M–1.15%
Mpm Bioimpact LLC4,472,8434.64%$26.39MNew1.61%
JPMorgan Chase & Co4,354,7154.52%$24.52M−104,1360.00%
Great Point Partners LLC4,215,9304.38%$24.87M–4.70%
Braidwell LP3,980,2954.13%$23.48M−8,6940.87%
Siren, L.L.C.3,734,8663.88%$22.04M–0.45%
BlackRock, Inc.3,614,6953.75%$21.33M+3,157,3360.00%
Commodore Capital LP3,250,0003.37%$19.18M–1.14%
Adage Capital Partners Gp, L.L.C.2,750,0002.85%$16.23M–0.02%
Saturn V Capital Management LP2,101,1192.18%$12.40M+1,361,1591.78%
QVT Financial LP1,895,1531.97%$11.18M+584,5600.67%
ADAR1 Capital Management, LLC1,759,2951.83%$10.38M+1,128,8920.48%
Armistice Capital, LLC1,636,0001.70%$9.65M+129,0000.12%
Geode Capital Management, LLC1,584,2091.64%$9.35M+1,056,5180.00%
Affinity Asset Advisors, LLC1,464,3031.52%$8.64M−1,100,0000.39%
Stempoint Capital LP1,368,2151.42%$8.07M−138,8251.39%
Ikarian Capital, LLC1,218,4921.26%$7.19M+25,0000.77%
EcoR1 Capital, LLC1,179,7151.22%$6.96M–0.34%
Vestal Point Capital, LP1,173,9561.22%$6.93M+662,9560.16%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 20269573M75.7%26 / 3219 / 2417M11M
Q1 20269467M69.4%32 / 3025 / 1126M3M
Q4 20257445M46.7%22 / 2518 / 129M10M
Q3 20256646M47.5%17 / 1524 / 1415M5M
Q2 20256435M36.7%21 / 1419 / 305M15M
Q1 20257346M47.5%6 / 2520 / 195M2M
Q4 20248743M44.5%25 / 3210 / 1410M4M
Q3 20247737M38.6%26 / 298 / 513M7M
Q2 20245733M34.2%18 / 2110 / 619M1M
Q1 20244515M15.5%5 / 1420 / 41M1M
Q4 20234415M15.9%10 / 243 / 72M1M
Q3 20234114M14.7%7 / 215 / 42M1M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

11 funds held ZURA in Q2 2026, 87% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of ZURAValue% of fundAs of
Vanguard Extended Market Index Fund747,3520.78%$4.41M0.00%Jun 30, 2026
ALPS Medical Breakthroughs ETF88,8790.09%$382.18K0.24%May 31, 2026
Nuveen Small Cap Blend Index Fund78,4640.08%$426.06K0.01%Jul 31, 2026
College Retirement Equities Fund - Total Global Stock Account47,7400.05%$281.67K0.00%Jun 30, 2026
Small Cap Index Fund30,4760.03%$179.81K0.01%Jun 30, 2026
Global X Russell 2000 ETF28,0640.03%$152.39K0.01%Jul 31, 2026
Avantis U.S. Small Cap Equity ETF25,8460.03%$111.14K0.00%May 31, 2026
Small Cap Index Trust12,5950.01%$74.31K0.01%Jun 30, 2026
SmallCap Growth Fund I5,0860.01%$27.62K0.00%Jul 31, 2026
Small Company Growth Portfolio4,4870.00%$26.47K0.10%Jun 30, 2026
Strategic Equity Allocation Trust2,7480.00%$16.21K0.00%Jun 30, 2026
Total Stock Market Index Trust1,6080.00%$9.49K0.00%Jun 30, 2026
Ultra Small Cap Profund7590.00%$4.12K0.01%Jul 31, 2026
Profund Vp Ultra Small Cap2420.00%$1.43K0.01%Jun 30, 2026
Profund Vp Small Cap1580.00%$9320.01%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Sandeep Chidambar KulkarniChief Executive Officer, Director––Apr 2, 2026
Robert LisickiChief Executive Officer, Director––Mar 3, 2025
Marlyn Teresa MathewVP, Principal Acctg. Officer129,1820.13%Jun 22, 2026
Gary WhaleChief Technology Officer––Apr 2, 2026
Eric J. HyllengrenChief Financial Officer––Apr 2, 2026
Kim DavisChief Legal Officer493,8810.51%Apr 2, 2026
Kiran NistalaSee Remarks3,1950.00%Apr 2, 2026
Verender S. BadialChief Financial Officer517,5190.54%May 12, 2025
Daniel J. BeckerDirector––Jun 22, 2026
Mark EisnerDirector––Jun 22, 2026
Ajay NirulaDirector––Jun 22, 2026
Jennifer JarrettDirector––Jun 22, 2026
Amit MunshiDirector777,3840.81%Jun 22, 2026
Steven J. SchochDirector––Jun 22, 2026
Parvinder ThiaraDirector0–Jun 22, 2026
van Amstel Arnout PloosDirector120,0000.12%May 22, 2025
Neil Murray Hamilton GrahamDirector––May 22, 2025
Someit SidhuDirector5,203,7155.40%May 22, 2025
Access Industries Management, Llc10% owner––Mar 2, 2026
Biotechnology LLC AI10% owner––Mar 2, 2026
Len Blavatnik10% owner––Mar 2, 2026
Industries Holdings LLC Access10% owner6,552,7256.80%Mar 2, 2026
Capital LLC UGS10% owner––Jan 2, 2026
Capital Athanor10% owner11,581,40212.02%Jan 2, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
Industries Holdings LLC Access
10% owner
Feb 26, 2026Buy+2,000,000$6.25$12.50M6,552,725
Parvinder Thiara
Director
Nov 25, 2024Sale−1,001,633$2.73$2.73M0
Kim Davis
Chief Legal Officer
Sep 16, 2024Award+1,000––1,500
Parvinder Thiara
Director
Sep 11, 2024Sale−3,800,000$2.70$10.26M1,001,633
Someit Sidhu
Director
Sep 4, 2024Other−593,055––242,055
Someit Sidhu
Director
Sep 4, 2024Sale−51,728$3.87$200.19K2,085,418
Someit Sidhu
Director
Aug 24, 2024Award+721,971––2,807,389
Someit Sidhu
Director
Aug 24, 2024Award+835,110––242,055
Verender S. Badial
Chief Financial Officer
Aug 23, 2024Award+126,155––517,519
Michael Howell
See Remarks
May 18, 2024Tax withholding−9,860$6.05$59.65K104,535
van Amstel Arnout Ploos
Director
May 17, 2024Buy+80,000$6.20$496.00K100,000
Kiran Nistala
See Remarks
Apr 22, 2024Award+3,195$3.13$10.00K3,195
Michael Howell
See Remarks
Apr 22, 2024Award+7,987$3.13$25.00K7,987
Amit Munshi
Director
Apr 22, 2024Award+159,744$3.13$500.00K777,384
Someit Sidhu
Director
Apr 22, 2024Award+1,186,901$3.13$3.72M1,186,901
Amit Munshi
Director
Apr 22, 2024Buy+159,744$3.13$500.00K777,384
Michael Howell
See Remarks
Apr 22, 2024Buy+7,987$3.13$25.00K7,987
Someit Sidhu
Director
Apr 22, 2024Buy+1,186,901$3.13$3.72M1,186,901
Kiran Nistala
Executive Vice President
Apr 22, 2024Buy+3,195$3.13$10.00K3,195
Parvinder Thiara
Director, 10% owner
Dec 12, 2023Sale−2,000,000$4.00$8.00M4,801,633
Someit Sidhu
Director
Nov 21, 2023Other−351,000––242,055
Kim Davis
Chief Legal Officer
Oct 1, 2023Award+500––500
Someit Sidhu
Director
Sep 28, 2023Other−761,370––242,055
Verender S. Badial
Chief Financial Officer
Sep 28, 2023Other+355,880––517,519
Someit Sidhu
Director
Sep 22, 2023Other−200,484––2,807,389
Verender S. Badial
Chief Financial Officer
Sep 22, 2023Other+35,484––517,519
Amit Munshi
Director
Jun 5, 2023Buy+117,647$4.25$500.00K617,640
Michael Howell
See Remarks
May 18, 2023Award+114,395––114,395
Christopher Cabell
CMO & Head of R&D
May 18, 2023Award+162,060––162,060
Kim Davis
Chief Legal Officer
May 18, 2023Award+492,381––492,381
Jeffrey A. Altman
10% owner
Mar 20, 2023Other−550,000$10.40$5.72M0
Someit Sidhu
Chief Executive Officer, Director, 10% owner
Mar 20, 2023Other+2,337,630––2,337,630
Someit Sidhu
Chief Executive Officer, Director
Feb 10, 2023Other−2,337,630––967,370
JATT Ventures, L.P.
10% owner
Feb 10, 2023Other−2,337,630––967,370

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
14.66%
8M shares short
Days to cover
1.8
At 5M shares a day
Change since last report
+20.7%
From 7M shares
Short volume, 20 days
45.3%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Zura Bio's stock actually held short. Settlement fails (shares not delivered on time) peaked at 18,272 shares on Sep 10, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Someit Sidhu
Director
Aug 18, 202650,000$287.71KAug 18, 2026Stock Option Exercise
Someit Sidhu
Director
Aug 17, 202627,000$151.34KAug 17, 2026Stock Option Exercise
Someit Sidhu
Director
Aug 14, 202640,000$220.54KAug 14, 2026Stock Option Exercise
Someit Sidhu
Director
Aug 13, 202651,000$287.04KAug 13, 2026Stock Option Exercise
Someit Sidhu
Director
Sep 4, 202452,000$200.00KSep 4, 2024Merger

See a number that looks wrong?